论文信息 - Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model. - 字舞流文

Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model.

G. Bormans | G. Van Simaeys | G. Doumont | J. Klaveness | B. Attili | D. Olberg | Syed Nuruddin | V. T. Lien | Sofie Celen